Status:
COMPLETED
Onduo Virtual Diabetes Clinic Study
Lead Sponsor:
Verily Life Sciences LLC
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a prospective, single arm study designed to evaluate the change in hemoglobin A1c after 4 months of participation in the Onduo Virtual Diabetes Clinic (VDC) in individuals with Type 2 diabetes...
Detailed Description
The Onduo Virtual Diabetes Clinic (VDC) is the suite of diabetes management services accessed via a software application (Onduo App). Eligible subjects are asked to use the Onduo App and commercially...
Eligibility Criteria
Inclusion
- Male and Female; 18 years of age or older
- Confirmed diagnosis of Type 2 diabetes mellitus
- Willing to use CGM and BGM
- A1c result ≥8.0% and ≤12.0%
- Receive their diabetes care from Premier Medical Associates or the Palo Alto Medical Foundation
- Own a Smartphone with a data plan and be the primary user of that smartphone
- Smartphone must use a supported Android OS or iOS
Exclusion
- Pregnant or breastfeeding
- Use of an insulin pump
- Any condition or situation that the Sponsor or Investigator determines as inappropriate for study inclusion
Key Trial Info
Start Date :
February 8 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 15 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03865381
Start Date
February 8 2019
End Date
October 15 2020
Last Update
September 24 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Palo Alto Medical Foundation
Palo Alto, California, United States, 94301
2
Premier Medical Associates
Monroeville, Pennsylvania, United States, 15146